Advances in the Management of Acute and Chronic Hyperkalemia

Activity Details

Accredited By

Target Audience

Community and community hospital-based generalist and specialist physicians, nurses, and pharmacists who manage patients with hyperkalemia.

Learning Objectives

• Assess for hyperkalemia risk in patients with underlying diseases like heart failure, diabetes, or chronic kidney disease
• Understand and differentiate among therapies for temporizing, acute, and chronic therapy for hyperkalemia
• Analyze the latest evidence-based data for hyperkalemia therapeutics to inform clinical decision making in an era of advanced treatment of heart failure, diabetes, and chronic kidney disease

Activity Description

Hyperkalemia and its important cardiometabolic comorbidities are increasingly common, while the most frequently used acute therapy to lower potassium levels for over five decades is now recognized as being associated with serious adverse effects. Over the last four years, clinical trial data has identified newer and safer therapeutic options. The goals of better potassium management include facilitation of guidelines-recommended therapy for heart failure and hypertension, and support of the patient with chronic renal disease. In this unique program, we will discuss new and improved options for managing hyperkalemia acutely and chronically. This information will impact the practices of emergency medicine physicians, hospitalists, internists, cardiologists, nephrologists, and other clinicians.

Statement of Educational Need

Health care team members need to understand the most recent clinical trial data regarding the treatment of management of patients with hyperkalemia.

Agenda

• Understand the Hyperkalemia Risk in Patients With Heart failure, Diabetes, or Chronic Kidney Disease
• Acute and Temporizing Management of Hyperkalemia
• Data Analysis and Interpretation: Applicability to Practice of Newer Potassium Binders

Faculty

Designation of Credit

AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

AcademicCME designates this enduring material for a maximum of 1.0 CNE Contact Hour (Provider Number P0491).

AcademicCME designates this continuing education activity for 1.0 CPE Contact Hour (0.10 CEU) of continuing pharmacy education credit (UAN #: JA4008190-0000-20-007-L04-P).

Participants should claim only the credit commensurate with the extent of their participation in the activity.

Method of Participation

In order to claim credit, participants must complete the following:

• Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
• Complete the Pre-Activity Questions.
• Read or review the activity content.
• Complete the Post-Activity Test Questions and Evaluation.
• Learners who receive a grade of 66% or better on the Post-Activity Test Questions and complete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).
  CPE credit will be posted to the learner’s CPE Monitor profile within 60 days of completion.
  CME and CNE credit will be issued appropriate certificate of completion.
  Others may request a “certificate of completion”.
• Learners should claim only the credit commensurate with the extent of their participation in the activity